Literature DB >> 10602740

Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS.

A Bicart-Sée1, P Massip, M D Linas, A Datry.   

Abstract

A patient with AIDS and chronic diarrhea caused by Enterocytozoon bieneusi was successfully treated with nitazoxanide, producing a complete clinical and parasitological response, while off of antiviral therapy. This suggests that nitazoxanide may be effective in treating microsporidiosis caused by E. bieneusi, a disease for which there is no established treatment.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10602740      PMCID： PMC89645          DOI： 10.1128/AAC.44.1.167-168.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Specific PCR assay for direct detection of intestinal microsporidia Enterocytozoon bieneusi and Encephalitozoon intestinalis in fecal specimens from human immunodeficiency virus-infected patients.

Authors:  C Ombrouck; L Ciceron; S Biligui; S Brown; P Marechal; T van Gool; A Datry; M Danis; I Desportes-Livage
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico.

Authors:  R Romero Cabello; L R Guerrero; M R Muñóz García; A Geyne Cruz
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

3.  Is the combination of hepatitis and indinavir potentially dangerous?

Authors:  F J Jeurissen; M M Schneider; J C Borleffs
Journal:  AIDS       Date:  1998-03-05       Impact factor: 4.177

4.  Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy.

Authors:  C N Conteas; O G Berlin; C E Speck; S S Pandhumas; M J Lariviere; C Fu
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

5.  Severe hepatitis in three AIDS patients treated with indinavir.

Authors:  N Bräu; H L Leaf; R L Wieczorek; D M Margolis
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

Review 6.  Diagnostic strategies in HIV-infected patients with diarrhea.

Authors:  H B Mayer; C A Wanke
Journal:  AIDS       Date:  1994-12       Impact factor: 4.177

7.  Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections.

Authors:  J F Rossignol; H Maisonneuve
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

8.  A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico.

Authors:  J F Rossignol; H Hidalgo; M Feregrino; F Higuera; W H Gomez; J L Romero; J Padierna; A Geyne; M S Ayers
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Nov-Dec       Impact factor: 2.184

9.  Screening of compounds for antimicrosporidial activity in vitro.

Authors:  E S Didier; J A Maddry; C D Kwong; L C Green; K F Snowden; J A Shadduck
Journal:  Folia Parasitol (Praha)       Date:  1998       Impact factor: 2.122

10.  Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.

Authors:  J M Molina; E Oksenhendler; B Beauvais; C Sarfati; A Jaccard; F Derouin; J Modaï
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226
View more
  10 in total

1.  A new and highly divergent Enterocytozoon bieneusi genotype isolated from a renal transplant recipient.

Authors:  Christelle Pomares; Monica Santín; Michel Miegeville; Anne Espern; Laetitia Albano; Pierre Marty; Florent Morio
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 3.  Microsporidia: Obligate Intracellular Pathogens Within the Fungal Kingdom.

Authors:  Bing Han; Louis M Weiss
Journal:  Microbiol Spectr       Date:  2017-04

4.  A Perspective on the Molecular Identification, Classification, and Epidemiology of Enterocytozoon bieneusi of Animals.

Authors:  Anson V Koehler; Yan Zhang; Robin B Gasser
Journal:  Exp Suppl       Date:  2022

5.  Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study.

Authors:  Yvonne Guttner; Helen M Windsor; Charlie H Viiala; Leon Dusci; Barry J Marshall
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 6.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

8.  Intestinal microsporidiosis in Strasbourg from 2014 to 2016: emergence of an Enterocytozoon bieneusi genotype of Asian origin.

Authors:  Valentin Greigert; Alexander W Pfaff; Ahmed Abou-Bacar; Ermanno Candolfi; Julie Brunet
Journal:  Emerg Microbes Infect       Date:  2018-06-06       Impact factor: 7.163

Review 9.  Current Therapy and Therapeutic Targets for Microsporidiosis.

Authors:  Junhong Wei; Zhihui Fei; Guoqing Pan; Louis M Weiss; Zeyang Zhou
Journal:  Front Microbiol       Date:  2022-03-09       Impact factor: 5.640

10.  Successful treatment of Enterocytozoon bieneusi gastrointestinal infection with nitazoxanide in a immunocompetent patient.

Authors:  Zaid Saffo; Najab Mirza
Journal:  IDCases       Date:  2019-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.